Doctor profile · Federal record

Dr. Pedro Sepulveda, M.D.

Specialist (CMS: Pulmonary Disease) · San Antonio, TX

  • NPI 1407931108
  • Accepts Medicare
  • MIPS 25.2 / 100 · 2023
  • 40 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
910 San Pedro Ave
San Antonio, TX 782124642
(210) 222-9575
fax (210) 222-9531

Credentials & registration

NPPES · NUCC
NPI registered
October 2006 — 20 yrs on file
Profile last updated
July 9, 2007
Year of graduation
1986 — 40 yrs since
Specialty taxonomy
174400000X — NUCC code
State license (1)
Texas #J6238

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1407931108. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,357
Distinct HCPCS
8
Medicare allowed
$181,339
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 850 399 $120
94060 Test to measure expiratory airflow and volume changes before and after medication administration 387 334 $36
94726 Test to determine lung volumes using sensors 293 271 $50
94729 Test to examine how well the lungs exchange gases 277 258 $52
94618 Test for exercise-induced lung stress 226 189 $31
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes 206 27 $71
99204 New patient office or other outpatient visit, 45-59 minutes 95 95 $157
94640 Inhalation treatment for airway obstruction or sputum production 23 22 $8

In context: peer comparison

Among 17 peers in San Antonio Specialist, average services per provider: 185. This provider delivers 13× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,432
Transactions
75
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals Lp 20 $572.40
GlaxoSmithKline, LLC. 17 $213.00
Boehringer Ingelheim Pharmaceuticals, INC. 10 $181.67
Insmed, INC. 13 $175.27
Pulmonx Corporation 2 $40.72
Mallinckrodt Hospital Products INC. 2 $38.27
Mylan Specialty L.P. 2 $30.93
United Therapeutics Corporation 1 $28.34
Fisher & Paykel Healthcare INC 1 $28.00
Takeda Pharmaceuticals U.S.A., INC. 1 $26.21
Regeneron Healthcare Solutions, INC. 1 $22.78
Astellas Pharma US INC 1 $22.69
3B Medical, INC. 2 $18.24
Baxter Healthcare 1 $17.75
Philips North America LLC 1 $16.09

By nature of payment

Food and Beverage
$1,432

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
8,269
Patients
2,409
Total drug cost
$5,959,442
Drug Type Claims Patients Total cost
Albuterol Sulfate Hfa (Albuterol Sulfate) Brand 2,330 613 $60,618
Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) Brand 1,274 253 $983,519
Montelukast Sodium Generic 945 217 $10,289
Prednisone Generic 551 283 $2,179
Breo Ellipta (Fluticasone/Vilanterol) Brand 417 96 $210,133
Omeprazole Generic 392 106 $4,384
Fluticasone Propionate Generic 385 138 $7,029
Famotidine Generic 345 118 $4,373
Symbicort (Budesonide/Formoterol Fumarate) Brand 345 77 $178,985
Ofev (Nintedanib Esylate) Brand 308 37 $4,169,314

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Pedro Sepulveda's medical specialty?
Dr. Pedro Sepulveda practices Specialist in San Antonio, TX.
Where does Dr. Pedro Sepulveda practice?
Dr. Pedro Sepulveda practices at 910 San Pedro Ave, San Antonio, TX 782124642. Office phone: 2102229575.
What is Dr. Pedro Sepulveda's NPI?
Dr. Pedro Sepulveda's National Provider Identifier (NPI) is 1407931108, issued by NPPES.
Does Dr. Pedro Sepulveda accept Medicare assignment?
Yes. Dr. Pedro Sepulveda accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Pedro Sepulveda commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS 94060); Test to determine lung volumes using sensors (HCPCS 94726). Source: CMS Medicare Physician & Other Practitioners file.